Literature DB >> 26175411

Genetic Classification of Gliomas: Refining Histopathology.

Michael B Foote1, Nickolas Papadopoulos1, Luis A Diaz2.   

Abstract

Newly published studies validate prior reports that specific combinations of genetic alternations in IDH1/2, ATRX, TERT, TP53, and co-deletion of 1p/19q have the ability to reclassify gliomas into rational subsets, defining a glioma's biological and clinical behavior more accurately than stratifications based solely on histopathology.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26175411     DOI： 10.1016/j.ccell.2015.06.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  20 in total

Review 1.  Epidermal growth factor receptor targeting and challenges in glioblastoma.

Authors:  Amy Haseley Thorne; Ciro Zanca; Frank Furnari
Journal:  Neuro Oncol       Date:  2016-01-10       Impact factor: 12.300

2.  Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.

Authors:  Yong Wang; Dandan Liang; Jimin Chen; Huan Chen; Rui Fan; Ye Gao; Yongsheng Gao; Rongjie Tao; Henghui Zhang
Journal:  Oncologist       Date:  2020-10-03

Review 3.  Extracellular Vesicles in Brain Tumor Progression.

Authors:  Esterina D'Asti; Shilpa Chennakrishnaiah; Tae Hoon Lee; Janusz Rak
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

4.  Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status.

Authors:  Marta Mellai; Laura Annovazzi; Rebecca Senetta; Carmine Dell'Aglio; Marta Mazzucco; Paola Cassoni; Davide Schiffer
Journal:  J Neurooncol       Date:  2016-10-28       Impact factor: 4.506

5.  Copy Number Profiling of Brazilian Astrocytomas.

Authors:  Lucas Tadeu Bidinotto; Raul Torrieri; Alan Mackay; Gisele Caravina Almeida; Marta Viana-Pereira; Adriana Cruvinel-Carloni; Maria Luisa Spina; Nathalia Cristina Campanella; Weder Pereira de Menezes; Carlos Afonso Clara; Aline Paixão Becker; Chris Jones; Rui Manuel Reis
Journal:  G3 (Bethesda)       Date:  2016-07-07       Impact factor: 3.154

6.  KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.

Authors:  Lihua Sun; Chuanbao Zhang; Zhengxiang Yang; Yiping Wu; Hongjun Wang; Zhaoshi Bao; Tao Jiang
Journal:  Oncotarget       Date:  2016-04-26

Review 7.  Drug repurposing for the treatment of glioblastoma multiforme.

Authors:  Claudia Abbruzzese; Silvia Matteoni; Michele Signore; Luca Cardone; Kavindra Nath; Jerry D Glickson; Marco G Paggi
Journal:  J Exp Clin Cancer Res       Date:  2017-11-28

Review 8.  The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.

Authors:  Sasha Beyer; Jessica Fleming; Wei Meng; Rajbir Singh; S Jaharul Haque; Arnab Chakravarti
Journal:  Cancers (Basel)       Date:  2017-07-10       Impact factor: 6.639

9.  CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.

Authors:  Luyan Mu; Changlin Yang; Qiang Gao; Yu Long; Haitao Ge; Gabriel DeLeon; Linchun Jin; Yifan Emily Chang; Elias J Sayour; Jingjing Ji; Jie Jiang; Paul S Kubilis; Jiping Qi; Yunhe Gu; Jiabin Wang; Yuwen Song; Duane A Mitchell; Zhiguo Lin; Jianping Huang
Journal:  Front Immunol       Date:  2017-11-07       Impact factor: 7.561

10.  The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme.

Authors:  Claudia Abbruzzese; Giada Catalogna; Enzo Gallo; Simona di Martino; Anna M Mileo; Mariantonia Carosi; Vincenzo Dattilo; Silvia Schenone; Francesca Musumeci; Patrizia Lavia; Nicola Perrotti; Rosario Amato; Marco G Paggi
Journal:  Oncotarget       Date:  2017-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.